OpGen Unyvero Pneumonia Panel Helps Curb Inappropriate Antibiotic Use in Prospective Trial
Genomeweb,
NEW YORK – An investigator-initiated, randomized controlled trial found that the use of OpGen subsidiary Curetis' Unyveras…
NEW YORK – An investigator-initiated, randomized controlled trial found that the use of OpGen subsidiary Curetis' Unyveras…
NEW YORK – An investigator-initiated, randomized controlled trial found that the use of OpGen subsidiary Curetis' Unyveras…